chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 02-AUG-2016 the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 5 microgram/0.5ml (thimerosal free, lot # M000442, expiration date 31-MAR-2018, dose and route unknown). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 56 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Vaccine received while living in an "Assisted Living" facility.   could walk, shower, clothe herself, etc.  On Sunday, January 31st. I, , her daughter and POA and Healthcare Surrogate, tried to call her two times.  Once at 4pm and again at 6pm.  No answer.   The next morning on February 1st, 2021, I received a call from her nurse that she had had a "stroke" and was being sent to Hospital.  I went to the hospital and spoke to her.  She could not move.  I told her that I had tried to contact her yesterday, Sunday, and she said he heard the phone but that she "could not move".   After her stay at the hospital, she has been moved to  Nursing and Rehab Center in .  She will be there for the rest of her life.    was healthy, and active (for her age) and happy.  She is now just waiting to die. I have given my address, as this is the only address for her.  She is "legally" blind and cannot read.  Which is a condition she had prior to the vaccine.  There is no question in my mind that the Pfizer vaccine gave my mother a "stroke".  I was advised by my doctor's office to submit this report to the VAERS system.  Thank you...
pt recvd vax 21DEC93 & began crying early AM 24DEC93 & would not stop for 7-8 hrs; was taken to FMD & could find no reason for the cont crying x/pertussis vax;
No adverse effect reported; improperly stored V ARlV AX; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history and current conditions was not provided.   On 23-OCT-2019, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S015459, expiration date 20-MAY-2021; frequency and dose number were unknown) subcutaneously for prophylaxis (product storage error). The temperature range was 14 degrees Celsius below zero to 10 degrees Celsius below zero for 2 hours 11 minutes. There was no previous temperature excursion for the product. Enclosed was temperature logger. The sterile diluent used for reconstitution did not experience an excursion. No adverse effect were reported. No product quality complaint (PQC) was involved.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported for similar event for two patients. This is the second of two reports. An adolescent patient of an unspecified ethnicity and gender received the first dose of TRUMENBA, via an unspecified route of administration from an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced terrible muscle pain. It was reported that the event took place after use of product. Outcome of the event was unknown. Sender's Comments: Linked Report(s): US-PFIZER INC-2017453955 same reporter/drug/event, different patient.
Pain in arm "like I had been punched" with continued pain in are followed by numbness and tingling in hands and fingers (ongoing).
Fever, muscle pain, vomiting, weakness, headache started at 7pm 8/12/10. Was seen and treated by PCP on 8/13/10 - was given OMNICEF, PHENERGAN, CELEBREX. Follow-up 8/23/10 and was 95% better and symptoms were resolving.
Swelling on left upper arm near the injection site. Look like red legion. Itchy on the arm and soar to touch. Started a week after first vaccine. Also found a vaginal bump on my inner labia.
Pt received hep B adult dose 4/26/06.Basically by 4/30/06 broke out with herpes, mild case, painful. No previous eruptions.
Patient had massive acute intracranial hemorrhage. Was found down in bathroom. In ED CT scan showed large intraventricular hemorrhage, EVD placed, patient progressed to massive brain swelling and infarctions, decompressive craniectomy, unable to control intracranial pressure, parents agreed to DNR status and patient is not expected to survive.
pt c/o pain @ inj site in lt arm & in shoulders;reported on 19SEp97 was unable to move arm w/o pain & reports pain when lifting lt arm;pt did not see a MD;
Pt. fully vaccinated with Pfizer dose 1 on 1/5/21 and dose 2 on 1/26/21. Pt. reports COVID symptoms of Cough, runny nose, loss of taste and smell, headache, fatigue, sore throat  starting 9/2/21.  Pt. worked 8/31/21, 9/1/21, 9/2/21, 9/3/21, 9/4/21, 9/5/21, 9/6/21, 9/7/21  at ER while symptomatic.  Pt. then tested COVID positive on 9/7/21 at Hospital.
Dizziness, head fog, tingling in hands and arms, soreness at injection site, nausea, fever, body aches, chills, chest pain I took Advil, drank water and slept
I received the shot about 4:45 pm on Thursday, October 16.  I was not feeling well that afternoon and evening: sneezing and some coughing.  I woke about 1 am the morning of Friday, October 17 with a high fever and a great deal of coughing. I was listless.  The site of the injection was painful (right arm, medial, shoulder)  I did not take my temperature until about 3 am and at that time it was 100.6 and climbing.  The fever increased to 101.2 by about 4:14 am at which time I took 1 table of 800 mg of Ibuprofen and 4, 500 mg capsules of amoxicillin that I am prescribed to take as a pre-medication for dentist visits.    I fell asleep and woke about 4 hour later and the fever was down, but the other symptoms persisted.    I continued to take 1 tablet / 1 capsule of the ibuprofen and amoxicillin at 4 hour intervals over Friday, Saturday, Sunday and into today (Monday).  The fever is under control and I am slowly improving.  Additional information for part 13, line 1.  The vaccine manufacturer is Evans
Janssen COVID-19 Vaccine EUA Symptoms started yesterday, March 9th, with muscle aches in my lower back a couple hours after receiving the shot. The muscle aches spread throughout my body as time went on, and joint pain and headaches came as the muscle aches worsened. I took two ibuprofens, though they had no effect. A bit later in the day, I developed a fever and felt very nauseous. When I went to sleep, I had a hard time staying asleep and ended up vomiting when I woke up at around 1:00AM. Today, March 10th, I continue to have muscle aches, joint pain, a headache, and slight nausea.
dizziness; heaviness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included PFIZER BIONTECH COVID 19 VACCINE, first dose on an unspecified date for COVID-19 immunization. The patient had her second covid vaccine shot and experienced dizziness and heaviness on an unspecified date with outcome of unknown. She asked if these are normal for people to experience once they had the covid vaccine.  Information about lot/batch number requested.
One of five pts who recvd DTP/OPV/HIB exp swelling & redness @ DTP inject site & extreme irritability;
pt recvd vax & 3 hrs p/dose had rash & itching on arms legs & face; pt was seen by a MD;
01/22/2021- dizziness, weakness, palpitations and tachycardia still reoccurs until present date. 01/24/2021-developed swollen lymph nodes on jaws, neck, above collarbones and shoulders still present to this date. 0128/2021-very painful swollen left shoulder and above left clavicle with pain extending towards upper back to both scapula prompting urgent care visit where  high BP and heart rate were also elevated @199/133 and >100 respectively.  Amlodipine 5 mgs PO daily started.
pt recv vax 8MAY98 & sx of serum sickness began on 8JUN99;fever, arthralgia, arthritis, rash, myalgia;hosp & still undergoing treatment & medication;
Patient passed out after receiving COVID XBB booster and Fluzone vaccines. Patient stated he felt light headed, had difficulty seeing/blurred vision, and became unresponsive.  Legs elevated with assistance. Once responsive and regained balance,  pt was transferred to stretcher for monitoring. MD notified of symptoms. Juice and crackers offered. Discharged to home once stable and asymptomatic.
Patient had symptoms after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ADVERSE DRUG REACTION (Patient had symptoms after first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Patient had symptoms after first dose). At the time of the report, ADVERSE DRUG REACTION (Patient had symptoms after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.No concomitant medication was reported.
Hives, swollen glands, chills, difficult breathing, feeling unwell, rash, skin infection, muscle weakness, tiredness, weakness confusion, leg pain and wheezing.
This case was reported by a physician via call center representative and described the occurrence of shingles in a 76-year-old female patient who received SHINGRIX (batch number 9AS39, expiry date 13th July 2020) for prophylaxis. In May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: Two weeks before the reporting date, the patient developed shingles. The reporter provided lot number from medical record, but was unsure if lot number was from vial or carton.
INFLAMMATION AT INJECTION SITE; MUSCLE ACHE; REDNESS AT INJECTION SITE; HEADACHE; LEG PAIN; KNEE PAIN; MUSCLE KNOT; This spontaneous report received from a patient concerned a 35 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced muscle knot. On APR-2021, the subject experienced leg pain. On APR-2021, the subject experienced knee pain. On 10-APR-2021, the subject experienced inflammation at injection site. On 10-APR-2021, the subject experienced muscle ache. On 10-APR-2021, the subject experienced redness at injection site. On 10-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from inflammation at injection site, muscle ache, redness at injection site, and headache, and had not recovered from knee pain, muscle knot, and leg pain. This report was non-serious.
Sore arm after each dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm after each dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and RA.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after each dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after each dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. treatment medications were not reported.   This case was linked to MOD-2021-350754, MOD-2021-350729.
Information has been received from a healthcare worker concerning her 18 year old daughter who was vaccinated with the third dose of GARDASIL and later experienced intermittent pain or achiness in the arm where she received GARDASIL. Follow up information has been received from the healthcare worker and a nurse. It was reported that the 16 year old patient on 20-APR-2007 was vaccinated with the first dose of GARDASIL (Lot# 657617/0384U), on 8-AUG-2007 was vaccinated with the second dose of GARDASIL (Lot# 655620/0171U) and on 9-NOV-2007 was vaccinated with her third dose of GARDASIL (Lot# 658560/1062U). After vaccinated the third dose of GARDASIL, the patient had pain in the arm where she received the GARDASIL and the pain was "on and off". The patient went on to receive the following vaccinations: MENACTRA, Lot# 02343AA, ADACEL, Lot# AC52B015AA and the first dose of HAVRIX, Lot# 1280F, all administered on 22-JAN-2008. The patient received the second dose of HAVRIX on 21-AUG-2008. Lot# 1280F. The nurse stated that the patient had an appoint to see the physician on 08-MAY-2009. Additional information has been requested.
Approx. four or five days after vaccinations, developed rash with itch on lower right leg. Rash appear similar to internet photos of moderna rashes (except for location)
Developmental delay  This case was reported by a healthcare professional and described the occurrence of developmental delay in an 4 year-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine (Infanrix) for prophylaxis and hepatitis B vaccine recombinant (Engerix-B).  Concurrent vaccinations given at the same time included Ipol, pneumococcal, Varivax, ActHIB/Engerix-B. On 08 March 2002 the subject received the first dose of Infanrix (lot number DTaP538A2). The nurse reported that the subject received 2 other additional doses of Infanrix on 06 May 2002 and 25 July 2002. He received the first vaccination of Engerix-B on 20 July 2003 and the third dose on 07 May 2004.  The second dose (unspecified manufacturer) was given on an unspecified date.  Approximately three years later (after the first dose of Infanrix) on an unspecified date in June 2005, the subject experienced developmental disorders and autism was being ruled out.  According to the mother of the subject, he experienced "austism and PDD (pervasive developemental disorder)." At the time of reporting, on 21 July 2006, the events were resolved.
It started 5:30 day of shot when my Covid symptoms came back and stayed for about three weeks. I had shortness of breath, and I couldn't walk around. They said that wasn't a typical reaction. I filled out forms online and they said that wasn't an expected reaction to the shot. I had a few others at time and they said those were to be expected, except the shortness of breath. Shortness of breath lasted for about  until the 2-3 weeks before 2nd vaccine. It didn't happen immediately after vaccine with shortness of breath.. It was intermittent and I was able to sit down and catch my breath and it just felt like Covid.
patient complained of pain, swelling and redness at vaccine injection site at tell us chills/arthralgias starting at 2 am the day after the vaccine was given.
I was having arm , shoulder and stomach pain. I have been suffering with leg pain since the vaccine. I am now going to see a spinal surgeon. I have cyst on my nerves and I also have thyroid issues.
Initial report was received 11 August 2010 from a health care professional which involved a cluster of eight patients who tested positive for pertussis. Patient identifiers were provided for seven patients; two who had previously received ADACEL (captured in case numbers 2010-04349 and 2010-04350); and three who had previously received an unspecified TdaP vaccine (captured in this case (2010-04352) and in case numbers 2010-04353 and 2010-04354), and two patients who had not received ADACEL, but had previously received a full DtaP vaccination series (captured in case numbers 2010-04351 and 2010-04376). At the time of the report, no information was available for the eight unidentified patient. A 12-year-old male patient had received an injection of TdaP on 20 July 2009 (manufacturer, lot number, route and site of administration not reported) and 355 days later on 10 July 2010, he was diagnosed with pertussis. Laboratory test results were positive for pertussis. Outcome was not reported, and no further information was provided at the time of report. Documents held by sender: None.
Anaphylaxis, angioedema. Unresponsive to epinepherine, steroids. Patient required intubation, mechanical ventilation, and ICU admission. Patient started on high dose steroids, BID IV famotidine, nebulizer therapy, with improvement in symptoms. Pt still in ICU at time of this submission.
The evening following the vaccine I had the normal flu like symptoms of headache, body aches, injection ache and fatigue. The next evening I had sudden onset of very strong metallic taste in my mouth and very strong smell of skunk.  Others with me did not smell or taste anything and we had the same meal prior to this coming on. The taste lasted until I woke up the next day and the smell subsided after about 2 hours. Diarrhea and fatigue this morning.  I informed my endocrinologist who told me it was due to the vaccine. I informed the pharmacist and he advised that I report it.
Reacted post vaccine 2 days ago, no fever, no previous vaccine reaction.  Recieved DTaP IM and VZV SQ but reaction started around DTaP area, painful to touch and itchy.  NAD SKIN R arm with erythema and swelling extends over 4 in x 3 in in area, warm to touch and tender, can mover arm all over, R arm circ=7 1/2 in, L arm is unaffected and circ=6 1/2 in.
Bed-ridden for the next 24 hours after the shot; Headache; joint ache; Fever; Slept on and off for a day; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of bedridden in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced bedridden (Verbatim: Bed-ridden for the next 24 hours after the shot), headache (Verbatim: Headache), joint pain (Verbatim: joint ache), fever (Verbatim: Fever) and sleep disturbance (Verbatim: Slept on and off for a day). The outcome of the bedridden was resolved (duration 24 hrs) and the outcome of the headache, joint pain, fever and sleep disturbance were resolved (duration 1 day).   It was unknown if the reporter considered the bedridden, headache, joint pain, fever and sleep disturbance to be related to RSV vaccine.     It was unknown if the company considered the bedridden, headache, joint pain, fever and sleep disturbance to be related to RSV vaccine.   Additional Information: GSK Receipt Date: 16-SEP-2023 This case was reported by a patient via interactive digital media. The patient received RSV vaccine and experienced bed ridden for the next 24 hours, headache, joint ache, fever and slept on and off for a day. Follow-up would not possible as no contact details were available.
Never have had menstrual issue untill now after getting first period after trying shot last week.  Heavy period. Multiple With large clotting. Some clots larger then half dollars. For over a 2 hours.  Which have never experienced before. Also muscle aches that are abnormal and breast pain
She got the vaccinated at 6:30; she sat until 6:40. by 6:45 she had a reaction started breaking into hives and turning red, itching, sweating blood, pressure 142/101. They gave her the reaction medication. At 7:20 checked blood pressure again 135/89. And she left after that.
Ovoid rash about 7cm diameter at injection site, as well as itchy, erythematous rash on back and bilateral arms. Rash appeared 1 day after vaccination, and has continued for several days; however patient reports rash was initially raised but is now flat. No medications given yet.
Vaccinated too low on her arm; Her skin became purple and green; Arm of the injection inflamed; Pain in also on the left side of her neck and goes down her chest; It is pain with burning sensation; Injection arm hurts a lot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION ERROR (Vaccinated too low on her arm), VACCINATION SITE DISCOLOURATION (Her skin became purple and green), VACCINATION SITE INFLAMMATION (Arm of the injection inflamed), NECK PAIN (Pain in also on the left side of her neck and goes down her chest) and PAIN (It is pain with burning sensation) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 001M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION ERROR (Vaccinated too low on her arm), VACCINATION SITE DISCOLOURATION (Her skin became purple and green), VACCINATION SITE INFLAMMATION (Arm of the injection inflamed), NECK PAIN (Pain in also on the left side of her neck and goes down her chest), PAIN (It is pain with burning sensation) and VACCINATION SITE PAIN (Injection arm hurts a lot). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 27-Feb-2021, VACCINATION ERROR (Vaccinated too low on her arm) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (Her skin became purple and green) and NECK PAIN (Pain in also on the left side of her neck and goes down her chest) outcome was unknown and VACCINATION SITE INFLAMMATION (Arm of the injection inflamed), PAIN (It is pain with burning sensation) and VACCINATION SITE PAIN (Injection arm hurts a lot) had not resolved.            The patient post receiving their second dose of vaccine complains of having vaccinated too low on their arm and not as high as the patient supposed it should be. The patient also reported that around the injection site and close to a vein that passes there, their skin became purple and green and was inflamed and was hurting a lot.   Reportedly, the pain was also there on the left side of their neck and it went down their chest. The patient's arm was hurting a lot whenever they wanted to exercise, and it was inflamed. The patient took ibuprofen, but the pain continued, and it was pain with burning sensation.  No Concomitant product use was reported.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-031334 (Patient Link).
Hidradenitis abcesses began to form on inner legs. Counted 4 in total in various sizes
pt recv vax 27JUN95 & 21JUN95 pt exp vaccine failure/chickenpox & was dx w/varicella;